The companies expanded their partnership to develop and commercialize messenger RNA (mRNA) cancer vaccines to include shared-antigen mRNA cancer vaccines such as mRNA-5671. / read more /
Subscribe
Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.
The European Union is collaborating with the Pharmaceutical Inspection Co-operation Scheme to develop similar guides for evaluating inspectorates' competency. / read more /
The company received a complete response letter from FDA in response to the biologics license application for a proposed rituximab biosimilar. / read more /
The data and analytics company reports on the anticipated uptake of Humira (adalimumab) biosimilars in the EU once they are launched in 2018. / read more /
The development of new packaging solutions for drugs of the future requires close collaboration between the pharmaceutical manufacturer and its packaging suppliers and machine vendors. / read more /
The high viscosity of concentrated monoclonal antibody formulations not only presents processing and storage difficulties, but also formulation and delivery challenges. / read more /
SMA MicroParticle ICSTM
VAI is pleased to announce the addition of the SMA MicroParticle ICS line of non-viable particle counters that utilize the latest innovation in particle counting technology, to our contamination control portfolio. / Read more/
Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible.
